The possible discrepancy between previous reports (from cell culture and murine models) and results of our clinical retrospective follow-up study underscores the need to better understand the (substrate) GalCer—(enzyme) Gal3ST1—(product) sulfatide axis in the RCC microenvironment. Here, GAL3ST1 is linked to renal cell adenocarcinoma.